Part, Chapter, Paragraph
1 II, 5. 10. 6| introduced in the market (e.g. novel foods, genetically modified
2 II, 5. 10. 7| allergenic potential of novel proteins. Mol Nutr Food
3 II, 5. 10. 7| potential human allergenicity of novel proteins: international
4 II, 6. 3. 2| bacteria’; and~· spotting novel ‘super strains’ where each
5 II, 6. 3. 6| Creutzfeldt-Jakob disease (vCJD) is a novel form of human spongiform
6 III, 10. 2. 1| brighter than white smile. Novel products featuring new uses
7 III, 10. 2. 1| benefits of existing and novel food products. The Action
8 III, 10. 2. 4| understanding of diseases, due to novel genome-based knowledge:~ ~·
9 III, 10. 2. 4| genome”.~ ~Besides that novel knowledge, also accompanying
10 III, 10. 2. 4| knowledge, also accompanying novel technologies, such as high-throughput
11 III, 10. 3. 3| Creutzfeldt-Jakob disease (vCJD) is a novel form of human spongiform
12 III, 10. 4. 2| reprogramming of genomes.~ ~GMOs and novel foods~ ~Novel foods are
13 III, 10. 4. 2| GMOs and novel foods~ ~Novel foods are foods and food
14 III, 10. 4. 2| for the authorisation of novel foods and novel food ingredients.~ ~
15 III, 10. 4. 2| authorisation of novel foods and novel food ingredients.~ ~Foods
16 III, 10. 4. 2| force of the Regulation on Novel Foods on 15 May 1997, are
17 III, 10. 4. 2| protection of human health, novel foods must undergo a safety
18 III, 10. 4. 2| authorised for marketing.~ ~Novel foods or novel food ingredients
19 III, 10. 4. 2| marketing.~ ~Novel foods or novel food ingredients may follow
20 III, 10. 4. 2| and the risk assessment of novel nanoparticles requires further
21 III, 10. 4. 2| January 1997 concerning novel foods and novel food ingredients.
22 III, 10. 4. 2| concerning novel foods and novel food ingredients. Official
23 IV, 11. 6. 5| transplantation: towards novel opportunities? Transplant
